Kathleen V Fitch

14PUBLICATIONS
56CO-AUTHORS
HaematologyDisease surveillanceCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Nov 06, 2025
Clonal Hematopoiesis and Major Adverse Cardiac Events in People With HIV: Insights From the REPRIEVE Trial.

Liying Xue, Romit Bhattacharya, Md Mesbah Uddin

|Sep 26, 2025
Risk Assessment in a Global CVD Prevention Cohort of People With HIV by PCE, PREVENT, and SCORE2.

Steven K Grinspoon, Sophia Zhao, Esteban Martinez

|Jun 27, 2025
Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot Substudy of the REPRIEVE Trial.

Michael J Corley, Maya Watanabe, Alina P S Pang

|Apr 26, 2025
Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People With HIV.

Steven K Grinspoon, Maya Watanabe, Heather J Ribaudo

|Apr 10, 2025
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort.

Emma Davies Smith, Carlos Malvestutto, Heather J Ribaudo

|Oct 22, 2024
Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV.

Markella V Zanni, Triin Umbleja, Carl J Fichtenbaum

Pageof 3